Domains and learning outcomes C109334

• One distance learning CPD point for optometrists.
• Clinical practice
Upon completion of this CPD, ECPs will be able to describe ocular conditions associated with harmful drug use and alcohol (s5)
Upon completion, ECPs will be able to describe the biochemical mechanisms underlying ocular damage caused by drugs and alcohol (s5)

This article delves into the detrimental effects of substances like smoking, alcohol, drugs and toxins on eye health, offering insights into screening methodologies and emphasising the importance of safety measures and treatment interventions within the framework of the Locsu clinical pathway on healthy living.

Introduction

In the realm of ocular health, the influence of lifestyle factors, particularly the consumption of harmful substances, emerges as a critical determinant of wellbeing, exerting profound effects on ocular physiology. Recent strides in research underscore a compelling association between substance abuse and ocular ailments, prompting a re-evaluation of traditional paradigms in eye care.1

At the core of this inquiry lies the acknowledgment of harmful substances as pivotal determinants of ocular health, with far-reaching implications for visual function.

Biochemical Mechanisms of Harmful Substance Impact on Eye Health

The deleterious effects of harmful substances on ocular health stem from their complex interactions with physiological and biochemical processes governing ocular homeostasis.2 Unravelling these mechanisms elucidates the pathways through which harmful substances undermine ocular integrity, paving the way for proactive measures to counteract their detrimental impact.

Absorption and metabolism

Harmful substances like nicotine, ethanol and psychoactive drugs are readily absorbed into the bloodstream upon ingestion, inhalation or injection. Once absorbed, these substances traverse systemic circulation, reaching ocular tissues via vascular networks.3 The rapid absorption and distribution of these substances facilitate their accumulation in ocular structures, where they exert toxic effects on cellular function and viability.

Oxidative stress and cellular damage

One of the primary mechanisms through which harmful substances impair ocular health is by inducing oxidative stress and cellular damage. Nicotine and alcohol, for instance, generate reactive oxygen species (ROS) within ocular tissues, leading to oxidative damage to cellular membranes, proteins, and DNA.4 Prolonged exposure to these oxidative insults exacerbates inflammation, compromises cellular integrity and contributes to the pathogenesis of ocular diseases such as cataracts and glaucoma.

Neurotoxicity and retinal dysfunction

Harmful substances exert neurotoxic effects on the retina, disrupting neurotransmitter signaling and neuronal function. Chronic alcohol consumption, for example, impairs retinal neurotransmission, alters visual processing and compromises visual acuity.5 Similarly, certain psychoactive drugs interfere with retinal neurotransmitter receptors, leading to aberrant neuronal activity and visual disturbances.6

Vascular impairment and ocular blood flow dysregulation

Another consequence of harmful substance abuse is the disruption of ocular blood flow dynamics, precipitating vascular dysfunction and ischemic injury. Nicotine, a vasoconstrictor, constricts retinal blood vessels, reducing ocular perfusion and predisposing to retinal ischemia.7 Similarly, alcohol-induced vasodilation disrupts retinal microcirculation, impeding nutrient delivery and waste removal, thereby exacerbating retinal pathology.8

Cellular toxicity and apoptosis

Prolonged exposure to harmful substances triggers apoptotic pathways in ocular cells, culminating in cellular death and tissue damage. Nicotine, for instance, induces apoptosis in retinal ganglion cells, exacerbating retinal neurodegeneration and contributing to visual impairment.9 Similarly, ethanol-mediated apoptosis in corneal epithelial cells compromises ocular surface integrity, predisposing to epithelial defects and infections.1

From impairing ocular blood flow to inducing retinal dysfunction, understanding the mechanisms underlying the deleterious effects of harmful substances on eye health offers critical insights into their pathophysiology and informs targeted interventions aimed at mitigating their impact.

Types of Harmful Substances and Ocular Impact

1. Smoking

Smoking represents a significant risk factor for various ocular pathologies, contributing to the development and progression of conditions such as age-related macular degeneration (AMD), cataracts and dry eye syndrome. The harmful components of cigarette smoke, including nicotine, tar, carbon monoxide and a multitude of free radicals, instigate a cascade of detrimental effects within ocular structures, profoundly impacting visual health.

Nicotine, a primary addictive component of tobacco, exerts vasoconstrictive effects on ocular blood vessels, diminishing retinal perfusion and exacerbating hypoxic conditions within the retina.11 This compromised blood flow, coupled with the pro-inflammatory properties of nicotine, fosters a microenvironment conducive to oxidative stress and chronic inflammation in retinal tissues. Consequently, the delicate architecture of the macula, essential for central vision, becomes increasingly susceptible to damage, predisposing individuals to the onset and progression of AMD, a leading cause of irreversible vision loss among the elderly.

Furthermore, cigarette smoke is laden with an array of free radicals and reactive oxygen species (ROS), byproducts of combustion processes, which inflict oxidative damage on ocular tissues. The retina, densely packed with polyunsaturated fatty acids and highly metabolically active, is particularly vulnerable to oxidative insult. Accumulation of ROS leads to lipid peroxidation, protein denaturation, and DNA damage within retinal cells, culminating in photoreceptor dysfunction, retinal pigment epithelial degeneration and, ultimately, vision impairment characteristic of AMD.12, 13



In addition to its deleterious effects on the retina, smoking significantly heightens the risk of cataract formation. The toxic constituents of cigarette smoke, upon absorption into the aqueous and vitreous humour, induce oxidative modifications in lens proteins, disrupting their structural integrity and transparency. This oxidative insult, compounded by reduced antioxidant defences within the lens, promotes the aggregation of denatured proteins, leading to the development of cataracts and subsequent visual impairment.14

Moreover, smoking exacerbates symptoms of dry eye syndrome, a multifactorial condition characterised by insufficient tear production or excessive tear evaporation.15 Cigarette smoke, laden with irritants and toxins, compromises the integrity of the ocular surface epithelium and disrupts the delicate balance of tear film composition. The resulting instability of the tear film exacerbates ocular surface inflammation and corneal epithelial damage, manifesting as ocular discomfort, blurred vision and foreign body sensation.

The detrimental impact of smoking on ocular health underscores the imperative of smoking cessation interventions in mitigating ocular morbidity and preserving visual function. Research indicates that quitting smoking can attenuate the progression of AMD, reduce the risk of cataract formation and ameliorate dry eye symptoms. By discontinuing tobacco use, individuals not only mitigate the ongoing insult to ocular tissues but also enhance their capacity for tissue repair and regeneration. Smoking cessation interventions, encompassing behavioural counselling, pharmacotherapy and support services, offer a tangible pathway to reducing the burden of smoking-related ocular diseases and improving long-term visual outcomes.

NHS guidance on smoking (and vaping)

The guidelines for smoking16 and vaping17 differ due to the distinct health risks associated with each activity. While both involve the inhalation of substances into the lungs, smoking typically refers to the combustion of tobacco or other plant materials, whereas vaping involves the use of electronic cigarettes or similar devices to aerosolise liquid formulations containing nicotine, flavourings and other chemicals.

  • Smoking

The NHS and other health organizations, including the UK government18 advocate for complete cessation due to the well-established health risks associated with tobacco smoke. Smoking tobacco exposes individuals to a myriad of harmful chemicals, including nicotine, tar, carbon monoxide and carcinogens, which can cause a range of serious health conditions, including various cancers, cardiovascular diseases, respiratory disorders and ocular diseases.

Consequently, the primary recommendation for smokers is to quit smoking altogether to reduce their risk of developing smoking-related health issues and improve their overall health outcomes.

  • Vaping

Vaping is often considered a harm reduction alternative to smoking,17 particularly for individuals who are unable or unwilling to quit nicotine use altogether. While vaping eliminates the combustion process and reduces exposure to many of the toxic byproducts found in cigarette smoke, it is not without risks. The long-term health effects of vaping are still being studied, but emerging evidence suggests that e-cigarette aerosols may contain harmful substances, including nicotine, ultrafine particles, heavy metals and volatile organic compounds, which could potentially pose health risks, including to eye health.

As such, the guidelines for vaping focus on harm reduction strategies and risk mitigation rather than complete cessation. The NHS advises individuals who smoke to consider switching to vaping as a less harmful alternative, particularly if other cessation methods have been ineffective. However, it is important for individuals considering vaping to understand that it is not risk-free, and that further research is needed to fully understand its health effects, including its impact on ocular health.

Additionally, the NHS emphasises the importance of regulation and quality control measures to ensure the safety of vaping products and protect public health. By promoting evidence-based information and providing support for smokers and vapers, healthcare professionals can help individuals make informed decisions about their tobacco and nicotine use and minimise the potential health risks associated with these behaviours, including those affecting eye health.

2. Alcohol

Excessive alcohol consumption poses a significant threat to eye health, precipitating the onset and progression of debilitating conditions such as alcoholic optic neuropathy and toxic amblyopia.19 These alcohol-related ocular disorders manifest as a constellation of visual disturbances, underscoring the pervasive impact of alcohol abuse on visual function and ocular integrity.

Alcoholic optic neuropathy represents a severe consequence of chronic alcohol abuse, characterised by irreversible damage to the optic nerve, the vital conduit for transmitting visual information from the retina to the brain. The toxic metabolites of alcohol, notably acetaldehyde, exert neurotoxic effects on optic nerve fibres, leading to demyelination, axonal degeneration and impaired signal transmission.20 This pathological cascade culminates in profound visual impairment, characterised by reduced visual acuity, colour vision deficits and constriction of the visual field. Peripheral vision loss ensues as the optic nerve fibres responsible for conveying peripheral visual stimuli succumb to alcohol-induced neurodegeneration.

Moreover, chronic alcohol abuse can precipitate the development of toxic amblyopia, a bilateral optic neuropathy characterised by symmetric visual deficits and optic nerve dysfunction. The precise pathophysiological mechanisms underlying toxic amblyopia remain incompletely understood but are believed to involve direct neurotoxic effects of alcohol metabolites on the optic nerve and retinal ganglion cells. Clinically, individuals with toxic amblyopia typically present with a gradual onset of visual symptoms, including blurred vision, central scotomas and impaired colour discrimination. The symmetrical nature of visual impairment distinguishes toxic amblyopia from other optic neuropathies, underscoring the etiological role of chronic alcohol abuse in its pathogenesis.

Furthermore, excessive alcohol consumption can exacerbate ocular surface dysfunction and precipitate dry eye syndrome, a multifactorial condition characterised by inadequate tear production or impaired tear film quality.22 Alcohol-induced dehydration compromises the hydration status of ocular tissues, leading to tear film instability, reduced tear secretion and ocular surface epithelial damage.23 Consequently, individuals with alcohol use disorder may experience symptoms of dry eye, including ocular irritation, foreign body sensation and visual fluctuations. The detrimental effects of alcohol-induced dehydration on ocular surface health underscore the importance of maintaining adequate hydration and mitigating alcohol consumption to preserve ocular comfort and visual wellbeing.

In summary, excessive alcohol consumption exacts a heavy toll on eye health, predisposing individuals to a spectrum of debilitating ocular conditions, including alcoholic optic neuropathy, toxic amblyopia, and dry eye syndrome. The neurotoxic effects of alcohol metabolites on the optic nerve and retinal tissues underpin the pathogenesis of these disorders, culminating in visual impairment and ocular surface dysfunction.

NHS guidance on alcohol

The NHS provides comprehensive guidelines on alcohol consumption, aiming to educate the public about the potential health risks associated with excessive drinking and promote responsible alcohol consumption habits.24, 25 These guidelines serve as valuable resources for individuals seeking to make informed decisions about their alcohol intake and mitigate the adverse effects on their health, including ocular health.

According to the NHS guidelines, both men and women are advised to limit their alcohol intake to no more than 14 units per week on a regular basis. This recommendation applies to all adults, irrespective of age or gender, and is designed to reduce the risk of developing alcohol-related health conditions, including those affecting eye health. Additionally, the guidelines emphasise the importance of spreading alcohol consumption evenly over three or more days, rather than consuming large amounts in a single session, to minimise the risk of harm to the body, including ocular tissues.

Furthermore, the NHS highlights the significance of alcohol-free days to allow the body time to recover from the physiological effects of alcohol and reduce the cumulative impact on health. Incorporating regular alcohol-free days into one’s routine can help prevent the onset of alcohol-related ocular disorders, such as alcoholic optic neuropathy and toxic amblyopia, by reducing overall alcohol consumption and mitigating the neurotoxic effects on ocular structures.

The NHS guidelines also provide specific recommendations for certain population groups, such as pregnant women, individuals with underlying health conditions and young adults under the legal drinking age. Pregnant women are advised to avoid alcohol altogether to minimise the risk of foetal alcohol spectrum disorders, including ocular abnormalities and visual impairments, in their offspring. Similarly, individuals with pre-existing eye conditions or systemic diseases affecting ocular health may need to exercise greater caution regarding alcohol consumption to prevent exacerbation of their condition.

Moreover, the NHS emphasises the importance of seeking professional help and support for individuals struggling with alcohol dependency or addiction. Specialist services, including addiction treatment programs and counselling support, are available to assist individuals in overcoming alcohol misuse and addressing the underlying factors contributing to their drinking behaviour. By accessing these resources, individuals can receive tailored interventions and support to reduce their alcohol intake and improve their overall health outcomes, including ocular health.

Incorporating the UK NHS guidelines on alcohol consumption into public health campaigns and clinical practice can enhance awareness of the risks associated with excessive drinking and empower individuals to make healthier lifestyle choices. By promoting responsible alcohol consumption habits and providing access to support services, healthcare professionals can play a vital role in preventing alcohol-related ocular disorders and safeguarding visual function for individuals across all age groups and demographics.

3. Illicit drugs

Illicit drugs, a category encompassing substances like cocaine, methamphetamine and heroin, pose significant threats to ocular health, precipitating a myriad of severe ocular complications attributable to their vasoactive and neurotoxic properties. These substances exert deleterious effects on ocular structures, culminating in a spectrum of ocular pathologies that underscore the detrimental consequences of drug abuse on visual function and ocular integrity.

  • Cocaine abuse represents a particularly pernicious threat to ocular health, predisposing individuals to a range of acute and chronic ocular complications. Acute angle-closure glaucoma may ensue following cocaine use, precipitating a sudden increase in intraocular pressure due to pupillary dilation and iris displacement.26 Retinal artery occlusion, a potentially sight-threatening condition characterised by the obstruction of retinal blood flow, can also occur, leading to irreversible retinal ischemia and visual loss.27 Additionally, optic neuropathy may develop secondary to cocaine abuse, manifesting as optic nerve dysfunction and progressive visual impairment.28
  • Methamphetamine abuse also poses grave risks to ocular health, with users facing an elevated likelihood of experiencing sight-threatening complications.29 Retinal haemorrhage, a hallmark feature of methamphetamine-induced retinopathy, may occur spontaneously or in association with sudden increases in blood pressure, leading to retinal vascular rupture and haemorrhagic sequelae. Central retinal artery occlusion, a devastating ischemic event resulting from the occlusion of the central retinal artery, represents another potential consequence of methamphetamine abuse, culminating in profound visual loss and retinal ischemia. Furthermore, methamphetamine-related ischemic optic neuropathy may ensue, characterised by optic nerve infarction and irreversible optic nerve damage.
  • Heroin abuse, often compounded by intravenous drug use and poor hygiene practices, carries a heightened risk of ocular complications, predisposing individuals to a spectrum of infectious and inflammatory ocular conditions.30 Infectious keratitis, a sight-threatening corneal infection typically arising from microbial contamination, may occur following heroin injection or ocular exposure to contaminated paraphernalia.31

Endophthalmitis, a severe intraocular infection involving the vitreous and ocular tissues, represents another potential consequence of heroin abuse, posing significant risks to visual function and ocular integrity. Additionally, orbital cellulitis, a potentially life-threatening condition characterised by periorbital inflammation and orbital tissue infection, may arise secondary to heroin-related complications, necessitating prompt medical intervention to mitigate systemic and ocular sequelae.

In summary, illicit drug abuse exacts a heavy toll on ocular health,32 predisposing individuals to a myriad of severe ocular complications, including acute angle-closure glaucoma, retinal artery occlusion, retinal haemorrhage, ischemic optic neuropathy, infectious keratitis, endophthalmitis and orbital cellulitis.

NHS guidance on illicit drugs

The NHS provides comprehensive guidance on the risks associated with illicit drug use, including the potential impact on overall health and wellbeing.33, 34 While the guidelines cover a wide range of health concerns related to drug misuse, including addiction, mental health issues and infectious diseases, they also address the specific risks to ocular health associated with certain drugs.

For example, cocaine use is known to have severe ocular complications due to its vasoactive properties, which can lead to conditions such as acute angle-closure glaucoma, retinal artery occlusion and optic neuropathy. The NHS advises individuals on the dangers of cocaine use and its potential to cause irreversible damage to the eyes, highlighting the importance of seeking medical help if experiencing visual disturbances or eye pain after using the drug.

Similarly, methamphetamine abuse is associated with a higher risk of retinal haemorrhage, central retinal artery occlusion and ischemic optic neuropathy. The NHS warns against the use of methamphetamine due to its potential to cause serious harm to the eyes and other organs, emphasising the need for individuals to seek support for substance misuse issues.

Moreover, heroin abuse carries risks of ocular complications, including infectious keratitis, endophthalmitis and orbital cellulitis, particularly among individuals who inject the drug intravenously. The NHS urges individuals to avoid heroin use and emphasises the importance of harm reduction measures, such as needle exchange programs, to minimise the risk of eye infections and other health consequences associated with drug injection.

Overall, the NHS guidelines on illicit drug use underscore the significant risks to ocular health posed by substances such as cocaine, methamphetamine and heroin. By providing evidence-based information and support for individuals struggling with drug misuse, the NHS aims to raise awareness of the potential consequences of drug use and empower individuals to make informed decisions about their health and wellbeing, including their ocular health.

Possible Clinical Implications for eye care practitioners (ECP)

As frontline healthcare providers, ECPs play a pivotal role in proactive health promotion.

Integrating screening protocols and safety measures within routine eye examinations could facilitate early detection of substance-related ocular pathology and prompt initiation of appropriate interventions. Also consider co-existing addictions as the likelihood of addiction to more than one substance is prevalent (ie a tobacco-alcohol dependent patient, or a tobacco-illicit drug patient).35 Moreover, collaboration with multidisciplinary healthcare teams and adherence to established clinical pathways, such as the Locsu clinical pathway on healthy living, may enhance the effectiveness of treatment and promote holistic patient care.36

This pathway emphasises the importance of lifestyle modifications, including smoking cessation and moderation of alcohol consumption, in promoting ocular health and reducing the risk of ocular diseases.36 By aligning with these clinical guidelines, and becoming aware of referral pathways,37 optometrists can optimise patient outcomes and contribute to the broader goal of promoting healthy living and preventing ocular morbidity.

Conclusion

In summary, the detrimental effects of harmful substances on eye health are multifaceted, encompassing oxidative stress, neurotoxicity, vascular impairment and cellular toxicity. Optometrists play a crucial role in mitigating these effects through proactive screening, patient education and evidence-based interventions. By integrating screening protocols, advocating for safety measures, and adhering to established clinical pathways, optometrists can optimise patient care and contribute to the preservation of ocular health in the face of substance abuse. 

  • Dr Sunni Patel is a multi-award-winning ultimate health and wellness coach and lifestyle medicine practitioner with a specialist interest in gut health and eating addiction. Certified and registered with the British Society of Lifestyle Medicine and an Affiliate of the Faculty of Homeopathy he has founded his own clinic supporting individuals 1:1 with personalised interventional programs to optimise physical, mental, emotional and spiritual health. You can contact Dr Sunni directly on info@dishdashdeets.com, on Instagram @drsunnipatel or LinkedIn as dr-sunni.
  • The author has no conflicting interests or financial disclosures to declare.

References

  1. Hussain ZS, Khan A, Loya A, Shah K, Woreta FA, Riaz KM. Early lifetime substance use and development of visual impairment: analysis of the national survey on drug use and health data. Clinical Ophthalmology. 2023 Dec 31:849-60.
  2. Fraunfelder FT, Fraunfelder FW, Chambers WA. Drug-Induced Ocular Side effects: clinical ocular toxicology E-Book: clinical ocular toxicology. Elsevier Health Sciences; 2014 Sep 19.
  3. Upadhyay RK. Transendothelial transport and its role in therapeutics. International scholarly research notices. 2014;2014.
  4. Rohowetz LJ, Kraus JG, Koulen P. Reactive oxygen species-mediated damage of retinal neurons: Drug development targets for therapies of chronic neurodegeneration of the retina. International Journal of Molecular Sciences. 2018 Oct 27;19(11):3362.
  5. Creupelandt C, d’Hondt F, Maurage P. Neural correlates of visuoperceptive changes in severe alcohol use disorder: a critical review of neuroimaging and electrophysiological findings. Journal of Neuroscience Research. 2021 May;99(5):1253-75.
  6. Ehinger B. Neurotransmitter systems in the retina. Retina. 1982 Oct 1;2(4):305-21.
  7. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Survey of ophthalmology. 1998 May 1;42(6):535-47.
  8. Kang HM, Woo YJ, Koh HJ, Lee CS, Lee SC. The effect of consumption of ethanol on subfoveal choroidal thickness in acute phase. British Journal of Ophthalmology. 2016 Mar 1;100(3):383-8.
  9. Lee K, Hong S, Seong GJ, Kim CY. Cigarette smoke extract causes injury in primary retinal ganglion cells via apoptosis and autophagy. Current eye research. 2016 Oct 2;41(10):1367-72.
  10. Oh JY, Yu JM, Ko JH. Analysis of ethanol effects on corneal epithelium. Investigative Ophthalmology & Visual Science. 2013 Jun 1;54(6):3852-6.
  11. Nita M, Grzybowski A. Smoking and eye pathologies. A systemic review. Part II. Retina diseases, uveitis, optic neuropathies, thyroid-associated orbitopathy. Current pharmaceutical design. 2017 Feb 1;23(4):639-54.
  12. Kunchithapautham K, Atkinson C, Rohrer B. Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation. Journal of Biological Chemistry. 2014 May 23;289(21):14534-46.
  13. Cano M, Thimmalappula R, Fujihara M, Nagai N, Sporn M, Wang AL, Neufeld AH, Biswal S, Handa JT. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and age-related macular degeneration. Vision research. 2010 Mar 31;50(7):652-64.
  14. Kumari RP, Ramkumar S, Thankappan B, Anbarasu K. Etiology and prevention of cataract. Studies on the cornea and lens. 2015:287-315.
  15. Li J, Zhang G, Nian S, Lv Y, Shao Y, Qiao N, Liang R, Huang L, Luo A. Dry eye induced by exposure to cigarette smoke pollution: An in vivo and in vitro study. Free Radical Biology and Medicine. 2020 Jun 1;153:187-201.
  16. https://www.nhs.uk/better-health/quit-smoking/. Accessed Online 13th May 2024
  17. https://www.nhs.uk/better-health/quit-smoking/vaping-to-quit-smoking/. Accessed Online 13th May 2024
  18. https://www.gov.uk/government/publications/smoking-and-tobacco-applying-all-our-health/smoking-and-tobacco-applying-all-our-health
  19. Berry RA, Denton WJ. Tobacco-Alcohol Amblyopia: Combined Toxic and Nutritional Optic Neuropathy. CRO (Clinical & Refractive Optometry) Journal. 2021 Jan 6;31(2).
  20. De La Monte SM, Kril JJ. Human alcohol-related neuropathology. Acta neuropathologica. 2014 Jan;127:71-90.
  21. Kesler A, Pianka P. Toxic optic neuropathy. Current neurology and neuroscience reports. 2003 Sep;3(5):410-4.
  22. You YS, Qu NB, Yu XN. Alcohol consumption and dry eye syndrome: a Meta-analysis. International journal of ophthalmology. 2016;9(10):1487.
  23. Karimi S, Arabi A, Shahraki T. Alcohol and the Eye. Journal of Ophthalmic & Vision Research. 2021 Apr;16(2):260.
  24. https://www.nhs.uk/better-health/drink-less/. Accessed Online 13th May 2024
  25. https://www.gov.uk/government/publications/delivering-better-oral-health-an-evidence-based-toolkit-for-prevention/chapter-12-alcohol. Accessed Online 13th May 2024
  26. Moreno-Castro L, García-García GP, Pérez-Santonja JJ. Acute Bilateral Angle-Closure Glaucoma Related to Intranasal Cocaine Abuse. Klinische Monatsblätter für Augenheilkunde. 2022 Jan;239(01):99-102.
  27. Leung IY, Lai S, Ren S, Kempen J, Klein R, Tso MO, Lai HC. Early retinal vascular abnormalities in African-American cocaine users. American journal of ophthalmology. 2008 Oct 1;146(4):612-9.
  28. Escolano-Serrano J, Monera-Lucas CE, Moreno-Escudero IM, Romero-Valero D, Fernández-Martínez C, Martínez-Toldos JJ. Optical neuropathy due to inhaled cocaine, causality or chance. Archivos de la Sociedad Española de Oftalmología (English Edition). 2020 Aug 1;95(8):411-4.
  29. Wallace RT, Brown GC, Benson W, Sivalingham A. Sudden retinal manifestations of intranasal cocaine and methamphetamine abuse. American journal of ophthalmology. 1992 Aug 1;114(2):158-60.
  30. Proulx V, Tousignant B. Drugs of abuse and ocular effects. Clinical and experimental optometry. 2021 Jul 4;104(5):567-78.
  31. Alipour F, Hashemi H, Pirim N, Asghari H. Ocular manifestations of transconjunctival heroin abuse: a case report of an unusual route of substance abuse. Cornea. 2010 Jan 1;29(1):110-2.
  32. Dhingra D, Kaur S, Ram J. Illicit drugs: effects on eye. Indian Journal of Medical Research. 2019 Sep 1;150(3):228-38.
  33. https://www.nhs.uk/live-well/addiction-support/. Accessed Online 13th May 2024
  34. https://www.gov.uk/government/publications/drug-misuse-and-dependence-uk-guidelines-on-clinical-management. Accessed Online 13th May 2024
  35. Schneider JP. Coexisting disorders. InAddiction counseling review 2004 Dec 13 (pp. 317-340). Routledge.
    https://locsu.co.uk/what-we-do/pathways/healthy-living-optical-practices-hlop-2/. Accessed Online 13th May 2024
  36. https://www.england.nhs.uk/long-read/guide-for-nhs-trust-tobacco-dependence-teams-and-nhs-trust-pharmacy-teams/. Accessed Online 13th May 2024